The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
Index/What The Tech?
What The Tech? artwork

How Possibility Neurotechnologies Is Making Brain-Controlled Interaction Accessible to Everyone

What The Tech? · 2026-04-13 · 20 min

0:00--:--

Topics in this episode

EngineeringBiotechNeurotechnologybrain scienceBioengineering

Episode notes

In our latest episode of What the Tech from Boast , we sat down with Dion Kelly, Co-Founder and CEO of Possibility Neurotechnologies, to discuss brain-computer interfaces, the power of getting comfortable being uncomfortable, and how Canadian non-dilutive funding programs are enabling groundbreaking neurotechnology innovation. Dion's journey is unconventional. She started with lemonade stands, redesigned secondhand clothes to sell at local markets by age 10, and planned to attend fashion school. Instead, she became one of the few researchers in the world with expertise in brain-computer interfaces, then built a company making brain-controlled interaction accessible to everyone. Her first product, Think2Switch™, is "a bit like Siri for your thoughts." It translates brain signals from off-the-shelf brain-sensing headsets into usable commands so you can control computers, toys, or smart devices using your thoughts. Boast accelerates the success of innovative businesses globally with software that integrates financial, payroll, and engineering data into a single platform of R&D intelligence. Visit Boast.ai ,

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

  • AI Should Make Us Better - Dr. Vivienne MingDon't Stop Us Now AI Edition · on Neurotechnology83 / 100
  • The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on Biotech81 / 100
  • The Frontier State of Nonprofit AcceleratorsThe Frontier State Podcast · on Biotech78 / 100
  • Deep Tech Gold Rush: Smart Boom or Future Bust?Venture Unlocked · on Biotech71 / 100
  • #113 - What was Fred Hoch from TechNexus doing in his 20sinTheir20s · on Biotech57 / 100
  • The Future of AI in Pharma, Diagnostics & Precision Medicine | Bill Taranto, President and Founding Partner & Dr. David Rubin, Managing Director - Merck Global Health Innovation FundProgress, Potential, and Possibilities Podcast / Show · on Biotech

More from What The Tech?

All episodes →
  • Bending Gravity To Build Houses Faster84 / 100
  • How Tech Thursday Became the Heartbeat of Canada's Prairie Tech Ecosystem44 / 100
  • The Secret Costs of Condo Living (And How CondoScan Decodes Them)51 / 100
  • The $50,000 Question: How Bōde is Fixing Home Selling67 / 100
  • Why Digital Transformation Still Matters in the AI Era
All What The Tech? episodes →